News Hub | News Direct

All Industries


Article thumbnail News Release

PathAI's AISight Dx Image Management System is CE Marked for Primary Diagnosis

PathAI

PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced that its AISight Ⓡ Dx Image Management System (IMS) is In Vitro Diagnostic Regulation (IVDR) certified for use in primary diagnosis. The CE mark paves the way for the company's expansion in the European diagnostic pathology market, enhancing pathologists' interpretations and driving efficiencies and quality improvements within anatomic pathology laboratories. "The IVDR certification demonstrates PathAI’s unwavering commitment to providing safe, effective, and high-quality diagnostic solutions," said Andy Beck, MD, PhD, co-founder and CEO of PathAI. "It not only confirms the compliance of our AISight platform with the latest European regulations but also strengthens our ability to assist pathologists in delivering accurate diagnoses and improving patient outcomes across Europe." AISight Dx is a robust digital pathology platform meticulously designed with input from over 200 pathologists to streamline end-to-end digital pathology workflows. It offers a suite of features including best-in-class caseload balancing and assignment, image ingestion, image viewing, collaboration tools, and image and case management. The platform can also seamlessly integrate bi-directionally with laboratory information systems through AISight Link, further enhancing workflow efficiency. Anatomic pathology laboratories of all sizes and specialties – including health systems, university hospitals, and reference laboratories – can leverage the benefits of AISight. "We are thrilled to expand our focus to bring the AISight Dx Image Management System to European labs. We look forward to partnering with European labs to democratize access to digital pathology, enhance the pathologist experience, and ultimately improve patient outcomes," said Nick Brown, Chief Growth Officer at PathAI. PathAI will be exhibiting at the European Congress of Pathology from September 7 to 11, 2024. To learn more about AISight and see a demo, visit us at booth #L145 or email digitaldx@pathai.com. About PathAI PathAI is a leading provider of integrated AI and digital pathology solutions, dedicated to transforming diagnostic accuracy and operational efficiency in pathology labs worldwide. Through innovative technologies and strategic partnerships, PathAI aims to enhance patient outcomes and drive the future of medical diagnostics. Contact Details SVM Public Relations and Marketing Communications Maggie Naples +1 401-490-9700 pathai@svmpr.com Company Website https://www.pathai.com/

August 28, 2024 03:00 AM Eastern Daylight Time

Article thumbnail News Release

AGC Biologics Strengthens Portfolio with Latest FDA Commercial Approval at Copenhagen Facility

AGC Biologics

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced the newest milestone at its Copenhagen Campus, a U.S. Food and Drug Administration (FDA) commercial approval for a biosimilar indicated for psoriasis, psoriatic arthritis, Crohn's disease and ulcerative colitis. This is the latest commercial biosimilar approval for the global CDMO, and a new milestone for its Copenhagen site. The expiration of patents for biologics products is driving new players to enter the biosimilar market and offer lower-cost alternatives for patients. Market value for this drug segment is expected to be more than $126 billion by 2032, a 17.6 percent CAGR between 2023 and 2032, according to a 2023 report. AGC Biologics offers key resources for biosimilar developers, such as flexible and scalable single-use manufacturing technology, the ability to scale production based on market demand, and strong expertise in managing quality control requirements needed to advance in each clinical phase. All these characteristics led to AGC Biologics’ Copenhagen site guiding this new product to FDA commercial approval. “We have one of the most extensive single-use technology bioreactor networks in the world. This allows us to start with the 2,000 L scale for product launch and scale out and utilize added vessels to reach larger batch sizes of 4,000 L, 6,000 L, 8,000 L etc. based on product demand in later phases. Through this economies-of-scale production model, we increase production for biosimilars as demand grows, while saving costs for our partners,” said Christoph Winterhalter, Chief Business Officer, AGC Biologics. “When you combine this element with our scientific quality expertise that emphasizes finding the Quality Target Product Profile (QTPP) – we are one of the best CDMOs available to help biosimilar developers meet clinical and commercial goals.” “This latest FDA achievement at our site demonstrates why we have been so successful,” notes Andrea Porchia, General Manager, AGC Biologics Copenhagen. “I continue to be impressed by this site and our team’s commitment to quality, productivity, and helping partners achieve their goals. We look forward to helping to produce this important treatment and providing patients in need with a new option to choose from other than what has been historically available.” The new commercial approval in the U.S. for this product comes after the AGC Biologics Copenhagen site announced the completion and opening of a new manufacturing building at its site in June, which more than doubled its single-use bioreactor capacity. The new 19,000 m2 ultramodern building offers a larger manufacturing floor, expanded quality control and process development lab space, and added utilities to support all operations at the site. AGC Biologics’ Copenhagen site core teams of scientists have more than 25 years of expertise in biopharmaceutical development and manufacturing, including seven commercial products brought to market. The site offers pre-clinical through commercial production for protein biologics services using mammalian and microbial systems and has a gold EcoVadis Sustainability Rating for its environmental, health, and sustainability practices. To learn more about AGC Biologics’ protein biologics manufacturing site in Copenhagen, visit https://www.agcbio.com/facilities/copenhagen. For more information on the company’s end-to-end global CDMO services in Europe, Japan, and the U.S. visit www.agcbio.com. About AGC Biologics: AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with a strong commitment to delivering the highest standard of service as we work side-by-side with our clients and partners, every step of the way. We provide world-class development and manufacture of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells. Our global network spans the U.S., Europe, and Asia, with cGMP-compliant facilities in Seattle, Washington; Boulder and Longmont, Colorado; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba, Japan. We currently employ more than 2,500 Team Members worldwide. Our commitment to continuous innovation fosters the technical creativity to solve our clients’ most complex challenges, including specialization in fast-track projects and rare diseases. AGC Biologics is a part of AGC Inc.’s Life Science Company. The Life Science company runs more than 10 global facilities focused on biopharmaceuticals, advanced therapies, small molecule active pharmaceutical ingredients, and agrochemicals. To learn more, visit www.agcbio.com. Contact Details Nick McDonald +1 425-419-3555 nmcdonald@agcbio.com Company Website https://www.agcbio.com/

August 28, 2024 12:05 AM Mountain Daylight Time

Article thumbnail News Release

Goodway Group Welcomes Rick Watrall as New Chief Data and Analytics Officer

Goodway Group

Goodway Group, a leading independent digital marketing agency, today announces the appointment of Rick Watrall to the new position of Chief Data and Analytics Officer. In this new role, Watrall will focus on evolving technical, data, and analytics priorities, and driving more value to clients through Goodway’s proprietary tech stack, GOES (Goodway’s Outcome Engineering System.) He will also guide critical decisions around investments in artificial intelligence to deliver faster, cheaper, and better solutions to marketers. This strategic hire is the latest indication of Goodway Group’s commitment to continued growth while delivering innovative solutions to its clients. With a deep understanding of modern marketers' needs, Watrall will be an invaluable addition as Goodway Group continues to innovate and lead in the industry. His arrival is perfectly timed, aligning with Goodway Group’s advancements in its award-winning GOES technology. GOES is a tech and data-enabled marketing system that powers Outcome Engineering—a proprietary philosophy that integrates strategy, analytics, and precise execution to drive measurable growth. Reporting directly to CEO Jay Friedman, Watrall’s leadership will further enhance Goodway Group’s ability to meet and exceed client expectations. Watrall joins Goodway Group from Horizon Media, where his strategic leadership and expertise over the past nine years helped shape the agency. During his tenure, he led a talented team of analysts, data scientists, and statisticians, contributing to the agency’s strategic planning and driving successful outcomes for major clients such as Capital One, Hershey, Revlon, Kohl’s, Mayo Clinic, Paramount and the NFL. Prior to Horizon Media, Watrall served as a senior partner at Hudson River Group where he specialized in marketing analysis, strategic and tactical marketing software, and ROI optimization. "We are thrilled to welcome Rick to the Goodway Group team," said Jay Friedman, CEO of Goodway Group. "His leadership, expertise, and passion will be instrumental in driving our data and analytics capabilities to new heights, ensuring we continue to deliver exceptional value to our clients." About Goodway Group Goodway Group is a leading independent digital marketing agency fueled by data, technology and a dedicated purpose of making your media investment perform. Goodway Group’s Outcome Engineering™ powers our full ecosystem, a proprietary philosophy that connects strategy, analytics and precise execution for measurable growth. Goodway Group ranks among the top North American agencies, earning prestigious awards for innovative marketing technology, impactful work and fostering inclusive, remote-first workplaces. We've been honored as a multiyear Ad Age Best Places to Work and received AdExchanger’s Best Use of Technology by an Agency award among other accolades. Our collective media buying power has led to industry-renowned partnerships. We hold certifications and are recognized with preferred partner status across the Triopoly and all major marketing and media platforms. This ensures that our clients' media investments are optimally managed, minimizing fraud and waste, and maximizing effectiveness and value. Our company encompasses five distinct divisions: CvE, a marketing advisory firm; G-Comm, a retail media accelerator; TUFF, a performance marketing agency; Goodway, a managed service media and analytics partner; and GRADIANT, a modern funnel digital media agency. Together, we make up Goodway Group, the marketing engine that unlocks measurable growth for the world's most progressive brands. Contact Details Kite Hill PR for Goodway Group +1 973-722-7881 goodway@kitehillpr.com Company Website https://www.goodwaygroup.com/

August 27, 2024 01:10 PM Eastern Daylight Time

Article thumbnail News Release

CWG Markets: Pioneering the Future of Trading Platforms with Dual Regulation and Cutting-Edge Technology

Rev Up Marketers

CWG Markets, a leading global trading platform, is revolutionizing the trading industry with its advanced technology, stringent regulatory oversight, and commitment to transparency. As financial markets evolve, CWG Markets continues to set new standards for excellence, providing investors with a secure and efficient environment for trading a diverse range of instruments. Dual Regulation: A Commitment to Security and Transparency CWG Markets Ltd (UK), registered in England and Wales (Company Number: 08888720), is fully authorized and regulated by the Financial Conduct Authority (FCA) under Firm Reference Number FRN 785129. The firm is also a member of the London Stock Exchange. Additionally, CWG Markets is regulated by the Vanuatu Financial Services Commission (VFSC) under Regulatory Number 41694. This multi-layered regulatory framework ensures that all transactions are conducted under stringent oversight, reinforcing the platform's commitment to security and transparency. Innovative Trading Platform Recognized Globally CWG Markets has developed a globally recognized trading platform equipped with a PAMM/MAM multi-account management system, designed to cater to a wide range of trading needs. The platform’s innovation and reliability have been acknowledged through numerous international awards, including "Best Online Broker" and "Most Trusted Broker." These accolades underscore CWG Markets’ leadership in the trading industry and its dedication to providing an exceptional trading experience. Diverse Trading Instruments and Competitive Trading Costs CWG Markets offers access to over 500 trading instruments, including CFDs, commodities, international securities, and global indices. The platform is known for its top-tier liquidity, rapid execution speeds, and competitive trading costs, with spreads as low as 0.0. Whether retail or professional, all users benefit from the platform's commitment to minimizing trading expenses and maximizing efficiency. Tailored Account Options for All Investors Understanding the diverse needs of its clients, CWG Markets offers four distinct account types: Instant, Standard, Advanced, and Institutional. Each account is designed to provide optimal trading conditions, with features such as EA services and varying leverage options. From beginners to seasoned professionals, CWG Markets ensures that every investor finds an account type that suits their trading strategy and risk preference. High-Performance Infrastructure and Transparent Trading Environment CWG Markets has invested heavily in state-of-the-art IT infrastructure to support complex trading applications. The trading servers, located in the LD5 data center in London, offer low latency and rapid order execution, supported by a robust liquidity pool. This infrastructure guarantees that all trades are executed fairly and without interference, providing a transparent and impartial trading environment. Commitment to Education and Customer Support In addition to its technological and regulatory strengths, CWG Markets is dedicated to educating its clients. The platform offers a comprehensive range of educational resources, including CWG TV, Daily Analysis, Technical Views, and Ebooks, ensuring that traders are well-informed and equipped to navigate the financial markets. Furthermore, CWG Markets provides exceptional customer service, with expert teams available to offer personalized guidance through various communication channels. About CWG Markets CWG Markets is a globally recognized trading platform offering a wide range of financial instruments and services. With dual regulation, innovative technology, and a steadfast commitment to transparency, CWG Markets is dedicated to delivering a secure and efficient trading experience for investors worldwide. For more information, visit CWG Markets. Contact Details CWG Markets Sami Rissaoui +60 1-800-81-9380 complaint@cwgmarkets.com Company Website https://cwgmarkets.com/

August 27, 2024 01:05 PM Eastern Daylight Time

Image
Article thumbnail News Release

BOSS Bonds Partners with Kingdom Bonding to Deploy SuretyBonds.Market Platform

Pinion Newswire

BOSS Bonds Insurance Agency, a subsidiary of General Indemnity Group (GIG), announced today it has partnered with Kingdom Bonding of Fairfax, VA to deploy BOSS Bonds’ industry-leading SuretyBonds.Market (SBM) platform. BOSS Bonds’ exclusive SBM platform is the leading technology solution for agents to deliver surety bond solutions to clients seamlessly. Industry experts meticulously crafted this advanced surety portal to streamline processes and enhance efficiency within the surety sector and throughout the surety value chain. The platform allows agents to monitor and manage their clients’ bonds throughout every stage, from application and underwriting to issuance and renewals. The SBM portal is supported by the surety experts at BOSS Bonds, allowing agents like those at Kingdom Bonding to focus on their specialty, while offering their clients the best surety solutions on the market. “We are excited that Kingdom Bonding has deployed SuretyBonds.market to unlock surety bond solutions for their construction and contractor customers,” said Rick Bredow, BOSS Bonds’ head of business development. “This partnership will allow Kingdom Bonding to better serve its customers online by putting advanced technology into the hands of insurance agents, allowing them to confidently capture more income in this often-overlooked segment of insurance.” “BOSS Bonds was instrumental in helping in the success of Kingdom Bonding, whose focus is to help minority-led construction companies achieve generational wealth and break free from poverty cycles,” said Neb Aynu, founder and owner of Kingdom Bonding. “Our purpose is to educate, nurture and grow bonding opportunities for our contractors. This technology helps us do just that by making it easy and seamless for those in the construction space to acquire contractor license bonds and other types of bond products.” Aynu also pointed out that the technology helps with better customer-facing and back-end systems for agents that provide all the support insurance agents selling bonds need. “The technology on the backend that BOSS Bonds offers allows our agency to perform operationally much more effectively and to better serve our customers. That coupled with actual live support offers a seamless bonding experience that only BOSS Bonds can offer.” Aynu admits that there was a higher calling for him to start Kingdom Bonding and after a year in business, it is coming to pass, “There is a huge racial wealth gap in this country and what I can do is make an impact on that inequity by helping minority contractors understand how to get bonded and to do so easily so they can get more business.” About BOSS Bonds Insurance Agency BOSS Bonds is a leading hub for comprehensive surety solutions. With over 40 years of experience among its agents, BOSS Bonds is licensed in all 50 states with the distinction of being a National Surety Managing General Agency. Its seasoned agents possess unparalleled insight into market preferences for various bonds, from securing the most competitive rates available to leveraging established relationships to securing the best bond programs tailored to a client’s needs. BOSS Bonds is a subsidiary of General Indemnity Group, LLC. General Indemnity Group General Indemnity Group, LLC (“GIG”) is an insurance holding company founded in 2015. It specializes in acquiring and operating companies that underwrite and distribute insurance products. GIG’s current holdings include surety insurance agencies, as well as an “A- Excellent” (AM Best rating) monoline surety insurance company. GIG is a wholly owned subsidiary of Boston Omaha Corporation, a public holding company with businesses engaged in diverse activities including advertising, real estate, insurance, broadband and other investments. For more information, visit www.bostonomaha.com. Learn more about GIG at www.gi.insure. Forward-Looking Statements Matters discussed in this press release may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbour protections for forward-looking statements to encourage companies to provide prospective information about their business. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, underlying assumptions and other statements, which are other than statements of historical facts. The Company desires to take advantage of the safe harbour provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbour legislation. The words “believe,” “anticipate,” “intends,” “estimate,” “forecast,” “project,” “plan,” “potential,” “may,” “should,” “expect,” “pending” and similar expressions identify forward-looking statements. The forward-looking statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions, including without limitation, our management's examination of historical operating trends, data contained in our records and other data available from third parties. Although we believe that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, we cannot assure you that we will achieve or accomplish these expectations, beliefs, or projections. Original Source of the original story >> BOSS Bonds Partners with Kingdom Bonding to Deploy SuretyBonds.Market Platform Contact Details BOSS Bonds Insurance Agency Randolph Pitzer +1 630-210-1631 rpitzer@pitzerrelations.com Company Website https://www.bossbonds.com/

August 27, 2024 12:28 PM Eastern Daylight Time

Article thumbnail News Release

Citi Remains Tactically Bullish on Uranium; Forecasts Price Rebound in 2024

MarketJar

On behalf of Generation Uranium Inc. Uranium has been a major investment theme over the past 18 months, with prices rising from below US$60/lb to over US$107/lb in February. Although the market has declined steadily since, leading many investors to question whether to hold or exit, Citi maintains a "tactically bullish" outlook for the market’s potential in 2024 and beyond. 1 Citi's latest research attributes the recent price stagnation to low trading volume and liquidity but expects a rebound as investor focus shifts. Citi forecasts uranium prices could rise to US$98/lb later this year, with an average of US$94/lb. By 2025, prices could reach US$110/lb, implying a potential upside of 36%. Citi points to increased uranium production as a factor in the recent price dip, with Kazakhstan's output expected to reach 59 million lbs this year. However, production growth is expected to slow sharply later in the decade. Meanwhile, inventories are projected to fall by 20 million lbs by 2030, putting uranium production back at the center of price determination. On the demand side, Citi notes the growing need for low-carbon energy and rising global power consumption. While no new nuclear plants are currently planned, Citi expects utilities to focus on extending plant life and restarting shuttered facilities, potentially boosting uranium demand, especially in the US. As the broader uranium market shows signs of a potential recovery, companies like Generation Uranium (TSXV:GEN) (OTCQB:GENRF) are well-positioned to capitalize on this trend through strategic projects and exploration initiatives. Generation Uranium is making significant strides with its Yath Uranium Project in Nunavut, Canada. 2 The company holds a 100% interest in this project, which is located in the prolific and under-explored Thelon Basin. Yath is strategically positioned along the trend of the Lac 50 uranium deposit, which contains 43 million lbs of uranium and is currently being developed by Latitude Uranium, a company recently acquired by ATHA Energy for $64.7 million in an all-share deal. 3 Historical exploration at Yath has consistently indicated uranium concentrations between 1% and 10% U3O8, underscoring its potential. In June, Generation Uranium acquired the Yellow Frog and Pink Toad Uranium Projects along the Angilak Trend in Nunavut, Canada. These acquisitions expand the Company's Yath Uranium Project by over 45%, bringing its total coverage to 123.45 km². Yath now extends northward, coming within 3 kilometers of Atha Energy Corp’s Angilak Project. Generation Uranium Partners With APEX Geoscience and ATHA Energy to Advance Yath Uranium Project In a further move to advance the Yath Project, Generation Uranium (TSXV:GEN) (OTCQB:GENRF) has partnered with APEX Geoscience. APEX will provide geological consulting services and assist in preparing and submitting exploration authorization applications for a planned diamond drilling campaign. This collaboration includes coordination with key regulatory bodies such as the Nunavut Planning Commission, Nunavut Impact Review Board, and Kivalliq Inuit Association to ensure compliance with all regulations. This partnership builds on historical data pointing to significant uranium potential at Yath, with past explorations and recent surveys by Kivalliq Energy affirming the high-grade uranium deposits. The collaboration with APEX Geoscience emphasizes Generation Uranium ’s commitment to utilizing expert insights and advanced technology to maximize the Yath Uranium Project’s potential, setting the stage for future development and regional economic growth. To accelerate exploration, Generation Uranium (TSXV:GEN) (OTCQB:GENRF) has launched an advanced airborne electromagnetic survey at the Yath Project, in partnership with ATHA Energy Corp. The survey is being conducted by Expert Geophysics Ltd., a leader in geophysical survey technology, using its cutting-edge Mobile MagnetoTellurics (MMT) system. This system, known for its precision, will employ the latest airborne AFMAG (Audio-frequency Magnetic) technology to identify electromagnetic (EM) anomalies across the 123.45 km² property. The survey will cover 890 line-kilometers with a 150-meter line spacing, gathering high-resolution magnetic and VLF data. The collaboration with ATHA Energy allows Generation Uranium to leverage economies of scale, reducing costs and speeding up the exploration process. CEO Anthony Zelen expressed confidence in the project, highlighting the strategic partnership and advanced technology as key factors in advancing Yath towards drilling. Click here for more information about Generation Uranium (TSXV:GEN) (OTCQB:GENRF). [1] https://www.marketindex.com.au/news/uranium-prices-will-rise-again-remain-tactically-bullish-citi [2] https://generationuranium.com/yath-project [3] https://generationuranium.com/news/b/guexploration Disclaimer 1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on research and understanding of the sector. 2) The Article was issued on behalf of and sponsored by, Generation Uranium Inc. Market Jar Media Inc. was paid $1,500 for the production and publishing of this article by Generation Uranium Inc.’s Digital Marketing Agency of Record (Native Ads Inc.). Additional details relating to Market Jar Media Inc.’s engagement by Generation Uranium Inc.’s Digital Marketing Agency of Record (Native Ads Inc.) are set out in https://pressreach.com/disclaimer-gen. 3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. Market Jar has not independently verified or otherwise investigated all such information. None of Market Jar or any of their respective affiliates, guarantee the accuracy or completeness of any such information. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy. 4) The Article does not constitute investment advice. All investments carry risk and each reader is encouraged to consult with his or her individual financial professional. Any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.'s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on pressreach.com should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on pressreach.com. 5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article. 6) This document contains forward-looking information and forward-looking statements, within the meaning of applicable Canadian securities legislation, (collectively, “forward-looking statements”), which reflect management's expectations regarding Generation Uranium Inc.’s future growth, future business plans and opportunities, expected activities, and other statements about future events, results or performance. Wherever possible, words such as “predicts”, “projects”, “targets”, “plans”, “expects”, “does not expect”, “budget”, “scheduled”, “estimates”, “forecasts”, “anticipate” or “does not anticipate”, “believe”, “intend” and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative or grammatical variation thereof or other variations thereof, or comparable terminology have been used to identify forward-looking statements. These forward-looking statements include, among other things, statements relating to: (a) revenue generating potential with respect to Generation Uranium Inc.’s industry; (b) market opportunity; (c) Generation Uranium Inc.’s business plans and strategies; (d) services that Generation Uranium Inc. intends to offer; (e) Generation Uranium Inc.’s milestone projections and targets; (f) Generation Uranium Inc.’s expectations regarding receipt of approval for regulatory applications; (g) Generation Uranium Inc.’s intentions to expand into other jurisdictions including the timeline expectations relating to those expansion plans; and (h) Generation Uranium Inc.’s expectations with regarding its ability to deliver shareholder value. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this document including, without limitation, assumptions about: (a) the ability to raise any necessary additional capital on reasonable terms to execute Generation Uranium Inc.’s business plan; (b) that general business and economic conditions will not change in a material adverse manner; (c) Generation Uranium Inc.’s ability to procure equipment and operating supplies in sufficient quantities and on a timely basis; (d) Generation Uranium Inc.’s ability to enter into contractual arrangements with additional parties; (e) the accuracy of budgeted costs and expenditures; (f) Generation Uranium Inc.’s ability to attract and retain skilled personnel; (g) political and regulatory stability; (h) the receipt of governmental, regulatory and third-party approvals, licenses and permits on favorable terms; (i) changes in applicable legislation; (j) stability in financial and capital markets; and (k) expectations regarding the level of disruption to as a result of CV-19. Such forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of Generation Uranium Inc. to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: (a) Generation Uranium Inc.’s operations could be adversely affected by possible future government legislation, policies and controls or by changes in applicable laws and regulations; (b) public health crises such as CV-19 may adversely impact Generation Uranium Inc.’s business; (c) the volatility of global capital markets; (d) political instability and changes to the regulations governing Generation Uranium Inc.’s business operations (e) Generation Uranium Inc. may be unable to implement its growth strategy; and (f) increased competition. Except as required by law, Generation Uranium Inc. undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither does Generation Uranium Inc. nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this document. Neither Generation Uranium Inc. nor any of its representatives shall have any liability whatsoever, under contract, tort, trust or otherwise, to you or any person resulting from the use of the information in this document by you or any of your representatives or for omissions from the information in this document. 7) Any graphs, tables or other information demonstrating the historical performance or current or historical attributes of Generation Uranium Inc. or any other entity contained in this document are intended only to illustrate historical performance or current or historical attributes of Generation Uranium Inc. or such entities and are not necessarily indicative of future performance of Generation Uranium Inc. or such entities. 8) The technical information contained in articles and videos produced for this campaign has been reviewed and approved by Mr. Derrick Strickland, P. Geo, (L5569) at Generation Uranium as the Qualified Person for the Company as defined in National Instrument 43-101. 9) Investing is risky. The information provided in this article should not be considered as a substitute for professional financial consultation. Users should be aware that investing in any form carries inherent risks, and as such, there is a possibility of losing some or all of their investment. The value of investments can fluctuate significantly within a short period, and investors must understand that past performance is not indicative of future results. Additionally, users should exercise caution as transactions involving investments may be irreversible, even in cases of fraud or accidental actions. It is crucial to acknowledge that rapidly evolving laws and technical issues can have adverse effects on the usability, transferability, exchangeability, and value of investments. Furthermore, users must be cognizant of potential security risks associated with their investment activities. Individuals are strongly encouraged to conduct thorough research, seek professional advice, and carefully evaluate their risk tolerance before engaging in any investment endeavors. Market Jar Media Inc. is neither an investment adviser nor a broker-dealer. The information presented on the website is provided for informative purposes only and is not to be treated as a recommendation to make any specific investment. No such information on PressReach.com constitutes advice or a recommendation. Contact Details James Young +1 800-340-9767 campaigns@pressreach.com Company Website https://pressreach.com

August 27, 2024 09:24 AM Eastern Daylight Time

Image
Article thumbnail News Release

E-commerce In The Age Of Artificial Intelligence

Benzinga

By Johnny Rice, Benzinga Dan Wagner, chairperson and CEO of Rezolve (NASDAQ: RZLV), was recently a guest on Benzinga’s All-Access. Rezolve Brain is an AI-powered platform for e-commerce businesses to optimize their online stores with enriched taxonomies, personalized recommendations and a conversational AI-powered shopping interface. Rezolve began trading on the NASDAQ this month. Watch the full interview here: Featured photo by Austin Distel on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

August 27, 2024 09:15 AM Eastern Daylight Time

Video Image
Article thumbnail News Release

Hospital and Health System M&A Remains Active in 2024, Reports Benchmark International

Benchmark International

Benchmark International, a leader in the mergers and acquisition (M&A) industry, has released its latest insights on the hospital and health system M&A landscape, revealing that merger and acquisition activity within the sector remains robust as the healthcare industry continues to navigate challenges and seize opportunities in 2024. According to Benchmark International’s latest report, the dynamics driving M&A activity in the healthcare sector include the need for increased operational efficiency, access to capital, and the pursuit of growth through strategic partnerships. Despite economic headwinds and ongoing regulatory scrutiny, the firm notes that many health systems are actively seeking consolidation opportunities to enhance their competitive positioning, expand service offerings, and ensure long-term sustainability. The report highlights several notable transactions in 2024, demonstrating the diverse motivations behind M&A deals, from scale-driven acquisitions to partnerships focused on expanding access to care. Benchmark International emphasizes that these trends are likely to persist as health systems continue to seek innovative ways to address the evolving demands of the healthcare landscape. As a trusted advisor with extensive experience in the healthcare sector, Benchmark International continues to guide clients through the complexities of M&A transactions, providing strategic insights and support to help them achieve their goals. For more information and to access the full article, please visit https://www.benchmarkintl.com/insights/2024-hospital-and-health-system-ma-remains-active/ ABOUT BENCHMARK INTERNATIONAL: Benchmark International is a global M&A firm that provides business owners with creative, value-maximizing solutions for growing and exiting their businesses. Benchmark International has handled over $11 billion in transaction value across various industries from offices across the world. With decades of M&A experience, Benchmark International’s transaction teams have assisted business owners with achieving their objectives and ensuring the continued growth of their businesses. The firm has also been named the Investment Banking Firm of the Year by The M&A Advisor and the Global M&A Network as well as the #1 Sell-side Exclusive Privately-held M&A Advisor in the World by Pitchbook and Refinitiv's Global League Tables. Contact Details Brittney Zoeller +1 813-898-2350 zoeller@benchmarkintl.com Company Website https://www.benchmarkintl.com/

August 27, 2024 09:00 AM Eastern Daylight Time

Image
Article thumbnail News Release

This Online Gaming And Sportsbook Company Is Looking At Growing In Brazil

Benzinga

By Johnny Rice, Benzinga Brian Goodman, CEO of Golden Matrix Group (NASDAQ: GMGI), was recently a guest on Benzinga’s All-Access. Golden Matrix Group Inc. is an established gaming technology company that develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers, located in the Asia Pacific region. Golden Matrix showed solid growth in its recent Q2 report. Watch the full interview here: Featured photo by Keenan Constance on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

August 27, 2024 09:00 AM Eastern Daylight Time

Video Image
1 ... 2728293031 ... 3725